{"id":52001,"date":"2022-12-14T21:02:25","date_gmt":"2022-12-14T20:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/"},"modified":"2022-12-14T21:02:25","modified_gmt":"2022-12-14T20:02:25","slug":"biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/","title":{"rendered":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5697519\/biologic-api-cdmo-benchmarking-for-new-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9wd2gv&amp;utm_campaign=1789958+-+Biologic+API+CDMO+Benchmarking+for+New+%26+Emerging+Biopharma%3A+Increased+Investment+and+Presence+of+Start-Ups+Galvanizes+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg\"><\/a><\/p>\n<p>\nBiological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma landscape within the biologics space. This analysis will help new and emerging biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.\n<\/p>\n<p>\nThe publisher understands the need for a deeper dive regarding the new and emerging biopharma landscape. This report provides pharmaceutical companies and contract manufacturers comprehensive analysis of current outsourcing trends and practices, CMO selection drivers, and CMO perceptions and interactions specific to the new and emerging audience. Findings are based on 119 service encounters from 45 respondents who have been involved in outsourced large molecule API projects in the past 18 months.\n<\/p>\n<p>\n<strong>What you will learn:<\/strong>\n<\/p>\n<p>\n<strong>New and Emerging Drug Developers:<\/strong>\n<\/p>\n<ul>\n<li>\nUncover which CMO attributes drive outsourcing partner selection for outsourced large molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers\n<\/li>\n<li>\nGain insight into CMO customer loyalty, based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience\n<\/li>\n<li>\nMake a more educated purchase of CMO services by understanding which manufacturers best fit your company&#8217;s needs\n<\/li>\n<\/ul>\n<p>\n<strong>Contract Manufacturers:<\/strong>\n<\/p>\n<ul>\n<li>\nUnderstanding your company&#8217;s competitive positioning and market awareness, and use this information to develop targeted messaging to new and emerging biopharma companies\n<\/li>\n<li>\nGain insight into drug developers&#8217; outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced large molecule API manufacturing\n<\/li>\n<\/ul>\n<p>\n<strong>Major Topics:<\/strong>\n<\/p>\n<ul>\n<li>\nOutsourcing Philosophies and Practices\n<\/li>\n<li>\nCMO Selection Drivers\n<\/li>\n<li>\nCMO Perceptions and Interactions\n<\/li>\n<li>\nStudy Data\n<\/li>\n<li>\nDemographics\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Copyright and Usage Guidelines<\/strong>\n<\/p>\n<p>\n<strong>How to Use this Report<\/strong>\n<\/p>\n<p>\n<strong>Analysis Note: Outsourcing Requirement<\/strong>\n<\/p>\n<p>\n<strong>Introduction<\/strong>\n<\/p>\n<p>\n<strong>Methodology<\/strong>\n<\/p>\n<p>\n<strong>Respondent Demographics and Qualifications<\/strong>\n<\/p>\n<p>\n<strong>Major Sections<\/strong>\n<\/p>\n<p>\n<strong>Outsourcing Philosophies and Practices<\/strong>\n<\/p>\n<ul>\n<li>\nPrimary Section Takeaways\n<\/li>\n<li>\nOutsourced Manufacturing Activities\n<\/li>\n<li>\nOutsourcing Drivers\n<\/li>\n<li>\nPreferred Providers\n<\/li>\n<li>\nNumber of Preferred Providers\n<\/li>\n<li>\nOutsourcing Models\n<\/li>\n<li>\nLarge Molecule Product Offering\n<\/li>\n<li>\nLarge vs Small Molecule Outsourcing\n<\/li>\n<\/ul>\n<p>\n<strong>CMO Selection Drivers<\/strong>\n<\/p>\n<ul>\n<li>\nPrimary Section Takeaways\n<\/li>\n<li>\nMost Important CMO Attributes\n<\/li>\n<li>\nCMO Attributes Gaining Importance\n<\/li>\n<\/ul>\n<p>\n<strong>CMO Perceptions and Interactions<\/strong>\n<\/p>\n<ul>\n<li>\nPrimary Section Takeaways\n<\/li>\n<li>\nCMO Familiarity\n<\/li>\n<li>\nCMO Leaders &#8211; Unprompted\n<\/li>\n<li>\nCMO Leaders &#8211; Prompted\n<\/li>\n<li>\nReceived Proposals\n<\/li>\n<li>\nCMO Use\n<\/li>\n<li>\nCMO Preference\n<\/li>\n<li>\nCMO Preference Among Users\n<\/li>\n<li>\nCMO Cost Perceptions\n<\/li>\n<li>\nSummary Table\n<\/li>\n<li>\nCMO Loyalty\n<\/li>\n<\/ul>\n<p>\n<strong>Study Data<\/strong>\n<\/p>\n<ul>\n<li>\nOutsourced Manufacturing Activities\n<\/li>\n<li>\nOutsourcing Drivers\n<\/li>\n<li>\nUse of Preferred Providers\n<\/li>\n<li>\nNumber of Preferred Providers\n<\/li>\n<li>\nOutsourcing Models\n<\/li>\n<li>\nLarge Molecule Product Offering\n<\/li>\n<li>\nLarge vs Small Molecule Outsourcing\n<\/li>\n<li>\nCMO Selection Attributes\n<\/li>\n<li>\nCMO Selection Attributes Gaining Importance\n<\/li>\n<li>\nCMO Familiarity\n<\/li>\n<li>\nCMO Leaders &#8211; Unprompted\n<\/li>\n<li>\nOther Responses (2%)\n<\/li>\n<li>\nCMO Leaders &#8211; Prompted\n<\/li>\n<li>\nReceived Proposals\n<\/li>\n<li>\nCMO Use\n<\/li>\n<li>\nCMO Preference\n<\/li>\n<li>\nCMO Cost Perceptions\n<\/li>\n<\/ul>\n<p>\n<strong>Demographics<\/strong>\n<\/p>\n<ul>\n<li>\nCompany Type\n<\/li>\n<li>\nHeadquarters Location\n<\/li>\n<li>\nOffice Location\n<\/li>\n<li>\nJob Title\n<\/li>\n<li>\nDecision-making Responsibility\n<\/li>\n<li>\nBiologic Drug Substance Outsourcing\n<\/li>\n<li>\nContract Manufacturing Responsibilities\n<\/li>\n<li>\nInvolvement in Outsourced Manufacturing\n<\/li>\n<li>\nContract Manufacturing Involvement\n<\/li>\n<li>\nYears of Industry Experience\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5697519\/biologic-api-cdmo-benchmarking-for-new-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9wd2gv&amp;utm_campaign=1789958+-+Biologic+API+CDMO+Benchmarking+for+New+%26+Emerging+Biopharma%3A+Increased+Investment+and+Presence+of+Start-Ups+Galvanizes+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/qigsa5<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;p&#114;&#x65;s&#x73;&#x40;&#114;&#x65;s&#101;&#x61;r&#x63;&#x68;&#97;&#x6e;d&#109;&#x61;&#114;&#x6b;e&#116;&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#101;&#115;&#x73;&#x40;&#x72;&#x65;se&#97;&#114;&#x63;&#x68;&#x61;&#x6e;dm&#97;&#114;&#107;&#x65;&#x74;&#x73;&#x2e;co&#109;<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-52001","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-14T20:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-14T20:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/\"},\"wordCount\":566,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005963\\\/en\\\/1665362\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/\",\"name\":\"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005963\\\/en\\\/1665362\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-14T20:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005963\\\/en\\\/1665362\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005963\\\/en\\\/1665362\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-14T20:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-12-14T20:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/"},"wordCount":566,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/","name":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg","datePublished":"2022-12-14T20:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221214005963\/en\/1665362\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biologic-api-cdmo-benchmarking-for-new-emerging-biopharma-increased-investment-and-presence-of-start-ups-galvanizes-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biologic API CDMO Benchmarking for New &amp; Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52001"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52001\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}